title: Presenting life with cystic fibrosis: a Q-methodological approach to developing balanced, experience-based prenatal screening information.
abstract: BACKGROUND
  Cystic fibrosis (CF) is one of the most common life-threatening genetically inherited conditions and prenatal screening for CF is available in many countries. Genetic counsellors and other health professionals are expected to provide information about the condition in a way that facilitates personal decision making. Knowing what information to deliver about complex genetic conditions to support informed screening decisions can be challenging for health professionals.
  
  
  OBJECTIVE
  To solicit views from those with personal experience with CF on which aspects of the condition they consider most important to include in prenatal screening materials.
  
  
  METHODS
  Q-methodology; an approach to systematically explore variations in viewpoint that combines factor analytic techniques with qualitative approaches to pattern interpretation.
  
  
  METHODS
  Twelve adults with CF and 18 parents of affected children were recruited from a regional centre in the UK.
  
  
  RESULTS
  Five distinct viewpoints on the items most and least important to include in screening information were identified: Factor 1 the normality of life with CF and increasing life expectancy; Factor 2 the hardships and reduced lifespan. Factor 3 medical interventions and the importance of societal support. Factor 4 longer-term consequences of CF. Factor 5 the ability to adjust to the condition.
  
  
  CONCLUSIONS
  The identification of five different views on what represented the most and least important information to include about CF highlights the challenge of portraying a complex genetic condition in a balanced and accurate manner. Novel ways in which Q-methodology findings can be used to meet this challenge are presented.
authors.affiliation: Bradford Teaching Hospitals Foundation Trust, Bradford, UK.
authors.forename: Katherine F
authors.initials: KF
authors.lastname: Wright
authors.affiliation: Leeds Institute of Health Sciences, University of Leeds, Leeds, UK.
authors.forename: Louise D
authors.initials: LD
authors.lastname: Bryant
authors.affiliation: Leeds Institute of Health Sciences, University of Leeds, Leeds, UK.
authors.forename: Stephen
authors.initials: S
authors.lastname: Morley
authors.affiliation: Leeds Institute of Health Sciences, University of Leeds, Leeds, UK.
authors.forename: Jenny
authors.initials: J
authors.lastname: Hewison
authors.affiliation: Leeds Teaching Hospitals NHS Trust, Leeds, UK.
authors.forename: Alistair J A
authors.initials: AJ
authors.lastname: Duff
authors.affiliation: Leeds Teaching Hospitals NHS Trust, Leeds, UK.
authors.forename: Daniel
authors.initials: D
authors.lastname: Peckham
mesh_terms: D000223:Adaptation, Psychological; D003550:Cystic Fibrosis / Q000175:diagnosis* / Q000235:genetics; D030881:Disclosure; D005260:Female; D005820:Genetic Testing; D006266:Health Education; D006291:Health Policy; D006801:Humans; D007407:Interviews as Topic; D011247:Pregnancy; D011296:Prenatal Diagnosis / Q000379:methods*; D011779:Q-Sort; D006113:United Kingdom
keywords: Q methodology; cystic fibrosis; prenatal screening information
references.citation: Prenat Diagn. 2001 Dec;21(12):1057-63
references.pmid: 11746164
references.citation: Health Expect. 2012 Jun;15(2):139-56
references.pmid: 21624022
references.citation: Soc Sci Med. 2006 Jul;63(1):32-42
references.pmid: 16431006
references.citation: J Pediatr. 2006 Sep;149(3):362-6
references.pmid: 16939748
references.citation: J Cyst Fibros. 2011 Jun;10 Suppl 2:S114-28
references.pmid: 21658631
references.citation: Disabil Soc. 1998 Nov;13(5):665-81
references.pmid: 11660717
references.citation: J Genet Couns. 2011 Apr;20(2):143-56
references.pmid: 21057975
references.citation: Ther Adv Respir Dis. 2010 Jun;4(3):177-85
references.pmid: 20530065
references.citation: Am J Med Genet A. 2011 Jun;155A(6):1246-57
references.pmid: 21548127
references.citation: Eur Respir J. 2007 Mar;29(3):522-6
references.pmid: 17182652
references.citation: Health Expect. 2007 Dec;10(4):309-20
references.pmid: 17986068
references.citation: Health Technol Assess. 2004 Aug;8(33):iii, ix-x, 1-109
references.pmid: 15298822
references.citation: Soc Sci Med. 2008 Dec;67(12):2079-88
references.pmid: 18951673
references.citation: Sociol Health Illn. 2005 Nov;27(7):873-96
references.pmid: 16313521
references.citation: Obstet Gynecol. 2011 Apr;117(4):1028-1031
references.pmid: 21422883
references.citation: Lancet. 2000 Apr 29;355(9214):1540-3
references.pmid: 10801187
references.citation: Patient Educ Couns. 2011 Dec;85(3):e291-8
references.pmid: 21652162
references.citation: Health Expect. 2001 Jun;4(2):92-8
references.pmid: 11359539
references.citation: Clin Genet. 2008 Nov;74(5):401-7
references.pmid: 18823383
references.citation: Am J Med Genet A. 2011 Aug;155A(8):1777-85
references.pmid: 21567935
references.citation: J Cyst Fibros. 2003 Dec;2(4):206-13
references.pmid: 15463875
references.citation: Genet Test. 2008 Mar;12(1):115-24
references.pmid: 18307384
references.citation: J Genet Couns. 2005 Feb;14(1):1-15
references.pmid: 15789152
references.citation: Am J Hum Genet. 1998 Oct;63(4):1181-9
references.pmid: 9758594
references.citation: Eur J Hum Genet. 2007 Oct;15(10):1012-22
references.pmid: 17568389
references.citation: Prenat Diagn. 2006 Sep;26(9):801-9
references.pmid: 16927359
references.citation: Ment Retard Dev Disabil Res Rev. 2003;9(1):40-7
references.pmid: 12587137
references.citation: Thorax. 2012 Jan;67(1):12-8
references.pmid: 21825083
references.citation: Health Expect. 2007 Dec;10(4):307-8
references.pmid: 17986067
references.citation: Sociol Health Illn. 2003 May;25(4):289-319
references.pmid: 14498923